Study of NM8074 in Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Interventions: Drug: NM8074; Drug: Placebo Sponsors: NovelMed Therapeutics Not yet recruiting

https://clinicaltrials.gov/study/NCT06226662

Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials

More News: Research | Study | Vasculitis